Status:
RECRUITING
Prognostic Model for Long-Term Cardiac Function After Pulmonary Embolism Based on Dynamic Electrocardial Signal and Circulating Biomarkers
Lead Sponsor:
China-Japan Friendship Hospital
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary embolism (PE) is a highly morbid and fatal cardiovascular disease. Right ventricular dysfunction (RVD) secondary to PE indicates a poor prognosis and serves as a critical basis for risk stra...
Detailed Description
Long-term functional impairment after acute PE has been increasingly concerned in recent years. Our previous meta-analysis indicated that 34% PE patients had RVD at 1 year after an acute episode. Howe...
Eligibility Criteria
Inclusion
- Age ≥18 years;
- Patients with confirmed diagnosis of PE (refer to the 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism);
- Onset ≤14 days from diagnosis; (4) Risk stratification of intermediate-low risk, intermediate-high risk, and high-risk according to the 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism;
- 5\) Patients agree to sign informed consent.
Exclusion
- A previous diagnosis of VTE with no evidence of recurrence, re-hospitalisation or treatment.
- Unable to attach the cardiac acquisition system due to chest surgery, localised damage, allergy, etc.
- Unable to complete the 1-year follow-up.
- Unable to operate portable mapping due to cognitive impairment, lack of a smartphone, etc.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06541353
Start Date
July 1 2024
End Date
June 30 2026
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029